Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

Effect of ipragliflozin, an SGLT2 inhibitor, on cardiac histopathological changes in a non-diabetic rat model of cardiomyopathy.

Takasu T, Takakura S.

Life Sci. 2019 Aug 1;230:19-27. doi: 10.1016/j.lfs.2019.05.051. Epub 2019 May 21.

PMID:
31125563
2.

Ovarian Mucinous Carcinoma with Mural Carcinosarcomatous Components in a Prepubertal Girl.

Suzuki K, Imada H, Igarashi A, Saitou Y, Takakura S.

J Pediatr Adolesc Gynecol. 2019 Apr 6. pii: S1083-3188(19)30178-0. doi: 10.1016/j.jpag.2019.04.005. [Epub ahead of print]

PMID:
30965111
3.

In Vitro Pharmacological Profile of Ipragliflozin, a Sodium Glucose Co-transporter 2 Inhibitor.

Takasu T, Yokono M, Tahara A, Takakura S.

Biol Pharm Bull. 2019;42(3):507-511. doi: 10.1248/bpb.b18-00728.

4.

Sub-classification of apraxia of speech in patients with cerebrovascular and neurodegenerative diseases.

Takakura Y, Otsuki M, Sakai S, Tajima Y, Mito Y, Ogata A, Koshimizu S, Yoshino M, Uemori G, Takakura S, Nakagawa Y.

Brain Cogn. 2019 Mar;130:1-10. doi: 10.1016/j.bandc.2018.11.005. Epub 2019 Jan 7.

PMID:
30622034
5.

Nippon AMR One Health Report: the first step towards multisectoral collaboration.

Jindai K, McLellan RT, Takakura S, Noda H, Miyake K.

Lancet Infect Dis. 2018 Nov;18(11):1179-1180. doi: 10.1016/S1473-3099(18)30566-8. Epub 2018 Oct 24. No abstract available.

PMID:
30507398
6.

First-dose effect of the SGLT2 inhibitor ipragliflozin on cardiovascular activity in spontaneously diabetic Torii fatty rats.

Takakura S, Takasu T.

Clin Exp Pharmacol Physiol. 2019 Mar;46(3):266-273. doi: 10.1111/1440-1681.13053. Epub 2018 Dec 27.

PMID:
30485488
7.

Clinical and Immunological Characterization of ICF Syndrome in Japan.

Kamae C, Imai K, Kato T, Okano T, Honma K, Nakagawa N, Yeh TW, Noguchi E, Ohara A, Shigemura T, Takahashi H, Takakura S, Hayashi M, Honma A, Watanabe S, Shigemori T, Ohara O, Sasaki H, Kubota T, Morio T, Kanegane H, Nonoyama S.

J Clin Immunol. 2018 Nov;38(8):927-937. doi: 10.1007/s10875-018-0559-y. Epub 2018 Oct 23.

PMID:
30353301
8.

First Major Practical Step toward Appropriate Antimicrobial Use by the Government of Japan.

Saito H, Noda H, Takakura S, Jindai K, Takahashi McLellan R, Asanuma K.

Jpn J Infect Dis. 2019 Jan 23;72(1):56-57. doi: 10.7883/yoken.JJID.2018.208. Epub 2018 Aug 31.

9.

Towards rubella elimination in Japan.

Jindai K, Funaki T, Nishijima T, Takakura S, Noda H, Miyake K.

Lancet Infect Dis. 2018 Jul;18(7):713-714. doi: 10.1016/S1473-3099(18)30356-6. No abstract available.

PMID:
29976516
10.

Protective Effect of Ipragliflozin on Pancreatic Islet Cells in Obese Type 2 Diabetic db/db Mice.

Takasu T, Takakura S.

Biol Pharm Bull. 2018;41(5):761-769. doi: 10.1248/bpb.b17-01007.

11.

Cytomegalovirus infection in living-donor and cadaveric lung transplantations.

Ohata K, Chen-Yoshikawa TF, Takahashi K, Aoyama A, Motoyama H, Hijiya K, Hamaji M, Menju T, Sato T, Sonobe M, Takakura S, Date H.

Interact Cardiovasc Thorac Surg. 2017 Nov 1;25(5):710-715. doi: 10.1093/icvts/ivx226.

PMID:
29049752
12.

Regulation of gut luminal serotonin by commensal microbiota in mice.

Hata T, Asano Y, Yoshihara K, Kimura-Todani T, Miyata N, Zhang XT, Takakura S, Aiba Y, Koga Y, Sudo N.

PLoS One. 2017 Jul 6;12(7):e0180745. doi: 10.1371/journal.pone.0180745. eCollection 2017.

13.

The Sodium Glucose Cotransporter 2 Inhibitor Ipragliflozin Promotes Preferential Loss of Fat Mass in Non-obese Diabetic Goto-Kakizaki Rats.

Takasu T, Hayashizaki Y, Hirosumi J, Minoura H, Amino N, Kurosaki E, Takakura S.

Biol Pharm Bull. 2017;40(5):675-680. doi: 10.1248/bpb.b16-00964.

14.

Ghrelin activation and neuropeptide Y elevation in response to medium chain triglyceride administration in anorexia nervosa patients.

Kawai K, Nakashima M, Kojima M, Yamashita S, Takakura S, Shimizu M, Kubo C, Sudo N.

Clin Nutr ESPEN. 2017 Feb;17:100-104. doi: 10.1016/j.clnesp.2016.10.001. Epub 2016 Oct 19.

15.

Functional imaging of pharmacological action of SGLT2 inhibitor ipragliflozin via PET imaging using 11C-MDG.

Mitsuoka K, Hayashizaki Y, Murakami Y, Takasu T, Yokono M, Umeda N, Takakura S, Noda A, Miyoshi S.

Pharmacol Res Perspect. 2016 Jul 1;4(4):e00244. doi: 10.1002/prp2.244. eCollection 2016 Aug.

16.

Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance.

Matsumura Y, Noguchi T, Tanaka M, Kanahashi T, Yamamoto M, Nagao M, Takakura S, Ichiyama S; 89th JAID BRG.

J Antimicrob Chemother. 2017 Apr 1;72(4):1040-1049. doi: 10.1093/jac/dkw530.

PMID:
28077674
17.

Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study.

Noguchi T, Matsumura Y, Yamamoto M, Nagao M, Takakura S, Ichiyama S.

BMC Infect Dis. 2017 Jan 7;17(1):44. doi: 10.1186/s12879-016-2150-6.

18.

Uterine artery pseudoaneurysm caused by a uterine manipulator.

Seki T, Hamada Y, Ichikawa T, Onota S, Nakata M, Takakura S.

Gynecol Minim Invasive Ther. 2017 Jan-Mar;6(1):25-27. doi: 10.1016/j.gmit.2016.04.002. Epub 2016 May 14.

19.

Executive Summary of Japanese Domestic Guidelines for Management of Deep-seated Mycosis 2014.

Kohno S, Tamura K, Niki Y, Izumikawa K, Oka S, Ogawa K, Kadota J, Kamei K, Kanda Y, Kiuchi T, Shibuya K, Takakura S, Takata T, Takesue Y, Teruya K, Tokimatsu I, Fukuda T, Maesaki S, Makimura K, Mikamo H, Mitsutake K, Miyazaki Y, Mori M, Yasuoka A, Yano K, Yamanaka N, Yoshida M.

Med Mycol J. 2016;57(4):E117-E163. Review. No abstract available.

20.

Regional Spread of CTX-M-2-Producing Proteus mirabilis with the Identical Genetic Structure in Japan.

Kato K, Matsumura Y, Yamamoto M, Nagao M, Takakura S, Ichiyama S.

Microb Drug Resist. 2017 Jul;23(5):590-595. doi: 10.1089/mdr.2016.0148. Epub 2016 Nov 11.

PMID:
27834610
21.

Visualization of mechanism of action, and a further therapeutic potential of ipragliflozin, a selective SGLT2 inhibitor.

Takasu T, Takakura S, Hamada K.

Nihon Yakurigaku Zasshi. 2016;148(5):266-271. doi: 10.1254/fpj.148.266. Japanese. No abstract available.

PMID:
27803440
22.

[Vancomycin-Resistant Enterococci].

Takakura S.

Rinsho Byori. 2016 Nov;64(11):1243-1248. Review. Japanese.

PMID:
30695305
23.

Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene.

Matsumura Y, Pitout JD, Gomi R, Matsuda T, Noguchi T, Yamamoto M, Peirano G, DeVinney R, Bradford PA, Motyl MR, Tanaka M, Nagao M, Takakura S, Ichiyama S.

Emerg Infect Dis. 2016 Nov;22(11):1900-1907. doi: 10.3201/eid2211.160519.

24.

Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.

Nagao M, Yamamoto M, Matsumura Y, Yokota I, Takakura S, Teramukai S, Ichiyama S.

Infection. 2017 Feb;45(1):83-91. doi: 10.1007/s15010-016-0946-3. Epub 2016 Oct 5.

PMID:
27709434
25.

Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.

Seki T, Tanabe H, Nagata C, Suzuki J, Suzuki K, Takano H, Isonishi S, Ochiai K, Takakura S, Okamoto A.

Jpn J Clin Oncol. 2017 Jan;47(1):32-38. doi: 10.1093/jjco/hyw145. Epub 2016 Sep 27.

PMID:
27677664
26.

MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma.

Yanaihara N, Noguchi Y, Saito M, Takenaka M, Takakura S, Yamada K, Okamoto A.

PLoS One. 2016 Sep 9;11(9):e0162584. doi: 10.1371/journal.pone.0162584. eCollection 2016.

27.

A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapy.

Hanaoka K, Kawato Y, Kubo K, Nakanishi T, Maeda M, Nakamura K, Hirose J, Noto T, Fukahori H, Fujikawa A, Miyoshi S, Takakura S, Morokata T, Higashi Y.

Transpl Immunol. 2016 Sep;38:19-26. doi: 10.1016/j.trim.2016.08.002. Epub 2016 Aug 19.

PMID:
27545900
28.

Interspecies Dissemination of a Mobilizable Plasmid Harboring blaIMP-19 and the Possibility of Horizontal Gene Transfer in a Single Patient.

Yamamoto M, Matsumura Y, Gomi R, Matsuda T, Tanaka M, Nagao M, Takakura S, Uemoto S, Ichiyama S.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5412-9. doi: 10.1128/AAC.00933-16. Print 2016 Sep.

29.

Erratum to: Seasonal trend and clinical presentation of Bacillus cereus bloodstream infection: association with summer and indwelling catheter.

Kato K, Matsumura Y, Yamamoto M, Nagao M, Ito Y, Takakura S, Ichiyama S.

Eur J Clin Microbiol Infect Dis. 2016 May;35(5):875-83. doi: 10.1007/s10096-016-2618-8.

PMID:
27010814
30.

Genetic, phenotypic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry-based identification of anaerobic bacteria and determination of their antimicrobial susceptibility at a University Hospital in Japan.

Yunoki T, Matsumura Y, Nakano S, Kato K, Hotta G, Noguchi T, Yamamoto M, Nagao M, Takakura S, Ichiyama S.

J Infect Chemother. 2016 May;22(5):303-7. doi: 10.1016/j.jiac.2016.01.014. Epub 2016 Feb 15.

PMID:
26898667
31.

Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats.

Takakura S, Toyoshi T, Hayashizaki Y, Takasu T.

Life Sci. 2016 Feb 15;147:125-31. doi: 10.1016/j.lfs.2016.01.042. Epub 2016 Jan 29.

PMID:
26829386
32.

Bundled strategies against infection after liver transplantation: Lessons from multidrug-resistant Pseudomonas aeruginosa.

Sato A, Kaido T, Iida T, Yagi S, Hata K, Okajima H, Takakura S, Ichiyama S, Uemoto S.

Liver Transpl. 2016 Apr;22(4):436-45. doi: 10.1002/lt.24407.

33.

In vitro activities and detection performances of cefmetazole and flomoxef for extended-spectrum β-lactamase and plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.

Matsumura Y, Yamamoto M, Nagao M, Tanaka M, Takakura S, Ichiyama S.

Diagn Microbiol Infect Dis. 2016 Apr;84(4):322-7. doi: 10.1016/j.diagmicrobio.2015.12.001. Epub 2015 Dec 11.

PMID:
26782634
34.

Risk factors for nosocomial tuberculosis transmission among health care workers.

Ito Y, Nagao M, Iinuma Y, Matsumura Y, Yamamoto M, Takakura S, Igawa J, Yamanaka H, Hashimoto A, Hirai T, Niimi A, Ichiyama S, Mishima M.

Am J Infect Control. 2016 May 1;44(5):596-8. doi: 10.1016/j.ajic.2015.11.022. Epub 2016 Jan 14.

PMID:
26777287
35.

Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.

Nagao M, Fujimoto Y, Yamamoto M, Matsumura Y, Kaido T, Takakura S, Uemoto S, Ichiyama S.

J Infect Chemother. 2016 Feb;22(2):84-9. doi: 10.1016/j.jiac.2015.11.005. Epub 2015 Dec 9.

PMID:
26683245
36.

Gut Dysbiosis in Patients with Anorexia Nervosa.

Morita C, Tsuji H, Hata T, Gondo M, Takakura S, Kawai K, Yoshihara K, Ogata K, Nomoto K, Miyazaki K, Sudo N.

PLoS One. 2015 Dec 18;10(12):e0145274. doi: 10.1371/journal.pone.0145274. eCollection 2015.

37.

Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.

Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Noguchi T, Yamamoto M, Matsumura Y, Nagao M, Takakura S, Ohnishi M, Ihara T, Ichiyama S.

Vaccine. 2016 Jan 2;34(1):67-76. doi: 10.1016/j.vaccine.2015.11.015. Epub 2015 Nov 19.

38.

Three cases of appendicitis with anorexia nervosa under inpatient care.

Takakura S, Yokoyama H, Suzuyama C, Tatsushima K, Yamashita M, Gondou M, Morita C, Hata T, Takii M, Kawai K, Sudo N.

J Eat Disord. 2015 Nov 6;3:38. doi: 10.1186/s40337-015-0076-9. eCollection 2015.

39.

Oral administration and younger age decrease plasma concentrations of voriconazole in pediatric patients.

Kato K, Nagao M, Yamamoto M, Matsumura Y, Takakura S, Fukuda K, Ichiyama S.

J Infect Chemother. 2016 Jan;22(1):27-31. doi: 10.1016/j.jiac.2015.09.008. Epub 2015 Nov 1.

PMID:
26538245
40.

Detection of Escherichia coli sequence type 131 clonal group among extended-spectrum β-lactamase-producing E. coli using VITEK MS Plus matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Matsumura Y, Yamamoto M, Nagao M, Tanaka M, Takakura S, Ichiyama S.

J Microbiol Methods. 2015 Dec;119:7-9. doi: 10.1016/j.mimet.2015.09.016. Epub 2015 Sep 28.

PMID:
26415529
41.

Changes in Surgical Site Infections after Living Donor Liver Transplantation.

Yamamoto M, Takakura S, Iinuma Y, Hotta G, Matsumura Y, Matsushima A, Nagao M, Ogawa K, Fujimoto Y, Mori A, Ogura Y, Kaido T, Uemoto S, Ichiyama S.

PLoS One. 2015 Aug 31;10(8):e0136559. doi: 10.1371/journal.pone.0136559. eCollection 2015.

42.

Development and evaluation of MALDI-TOF MS-based serotyping for Streptococcus pneumoniae.

Nakano S, Matsumura Y, Ito Y, Fujisawa T, Chang B, Suga S, Kato K, Yunoki T, Hotta G, Noguchi T, Yamamoto M, Nagao M, Takakura S, Ohnishi M, Ihara T, Ichiyama S.

Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2191-8. doi: 10.1007/s10096-015-2468-9. Epub 2015 Aug 19.

PMID:
26282790
43.

Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy.

Nagata C, Tanabe H, Takakura S, Narui C, Saito M, Yanaihara N, Okamoto A.

J Obstet Gynaecol Res. 2015 Sep;41(9):1440-8. doi: 10.1111/jog.12740. Epub 2015 Jun 26.

PMID:
26111609
44.

Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-β-lactamase-producing Escherichia coli bacteremia.

Matsumura Y, Yamamoto M, Nagao M, Komori T, Fujita N, Hayashi A, Shimizu T, Watanabe H, Doi S, Tanaka M, Takakura S, Ichiyama S.

Antimicrob Agents Chemother. 2015 Sep;59(9):5107-13. doi: 10.1128/AAC.00701-15. Epub 2015 Jun 22.

45.

Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.

Yanaihara N, Hirata Y, Yamaguchi N, Noguchi Y, Saito M, Nagata C, Takakura S, Yamada K, Okamoto A.

Mol Carcinog. 2016 May;55(5):832-41. doi: 10.1002/mc.22325. Epub 2015 Apr 9.

PMID:
25856562
46.

[Pharmacological and clinical profile of ipragliflozin (Suglat®): a new therapeutic agent for type 2 diabetes].

Takasu T, Takakura S, Kaku S.

Nihon Yakurigaku Zasshi. 2015 Jan;145(1):36-42. doi: 10.1254/fpj.145.36. Review. Japanese. No abstract available.

PMID:
25743234
47.

Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats.

Hayashizaki-Someya Y, Kurosaki E, Takasu T, Mitori H, Yamazaki S, Koide K, Takakura S.

Eur J Pharmacol. 2015 May 5;754:19-24. doi: 10.1016/j.ejphar.2015.02.009. Epub 2015 Feb 19.

PMID:
25701721
48.

CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.

Matsumura Y, Johnson JR, Yamamoto M, Nagao M, Tanaka M, Takakura S, Ichiyama S; Kyoto–Shiga Clinical Microbiology Study Group; Kyoto-Shiga Clinical Microbiology Study Group.

J Antimicrob Chemother. 2015;70(6):1639-49. doi: 10.1093/jac/dkv017. Epub 2015 Feb 16.

PMID:
25687644
49.

Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinoma.

Okamoto A, Sehouli J, Yanaihara N, Hirata Y, Braicu I, Kim BG, Takakura S, Saito M, Yanagida S, Takenaka M, Yamaguchi N, Morikawa A, Tanabe H, Yamada K, Yoshihara K, Enomoto T, Itamochi H, Kigawa J, Matsumura N, Konishi I, Aida S, Aoki Y, Ishii N, Ochiai K, Akiyama T, Urashima M.

PLoS One. 2015 Feb 6;10(2):e0116977. doi: 10.1371/journal.pone.0116977. eCollection 2015.

50.

High prevalence of carbapenem resistance among plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae during outbreaks in liver transplantation units.

Matsumura Y, Tanaka M, Yamamoto M, Nagao M, Machida K, Ito Y, Takakura S, Ogawa K, Yoshizawa A, Fujimoto Y, Okamoto S, Uemoto S, Ichiyama S.

Int J Antimicrob Agents. 2015 Jan;45(1):33-40. doi: 10.1016/j.ijantimicag.2014.08.015. Epub 2014 Oct 14.

PMID:
25455850

Supplemental Content

Loading ...
Support Center